Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Adults with atopic dermatitis treated with upadacitinib had fewer major adverse cardiovascular events compared with ...

Ten firms led a market rally with whopping gains on Thursday, outperforming the lackluster performance of the major indices ...

Discover the top stock picks by market experts Raja Venkatraman, MarketSmith India, Ankush Bajaj and Trade Brains for ...

Bimekizumab demonstrated a favorable safety profile for the long-term treatment of axSpA and PsA, with rates of TEAEs remaining stable over time.

John Mauceri had a complicated health history, but his sudden swelling and fatigue left his team of doctors stumped.

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a ...

On May 22, 2025, the FDA approved Bio-Thera Solutions and Hikma Pharmaceuticals’ ustekinumab biosimilar, STARJEMZA® (ustekinumab-hmny) ...

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...

John Mauceri, an award-winning music conductor, author, and recording artist, is celebrating his return to the stage in ...

UK-based biotech C4X Discovery has received an 8 million euro ($9 million) milestone payment from French pharma major Sanofi ...